Author's posts
How Obesity Puts You At Risk For Covid-19
A new Lancet study give us insight into why Covid-19 has more serious consequences for the obese and overweight.
Banning Large Public Gatherings And Closing Schools Significantly Slows Down Covid-19, Study Finds
As demonstrated by China and others, public health initiatives like school closures, public event bans, and mask mandates beat Covid-19 swiftly and effectively.
Lancet Study Suggests U.S. Is Massively Undercounting Covid-19 Cases
We are grossly undercounting the number of Americans with Covid-19.
What Are Autoantibodies? The Latest Risk Factor For Severe Covid-19
If antibodies are the defenders our B cells produce to battle oncoming infection, autoantibodies are defectors that do precisely the opposite. Rather than attacking viral genetic material, autoantibodies target us.
Kushner Comments Suggest Covid-19 Decisions Are Politically Motivated
Recently released audio of Jared Kushner suggests deferring action on reopening to the governors was a political calculation.
New York City Limits The Chances For In-Person Learning For Students
Parents of NYC school children must opt in to in-person learning by November 15— while new infections are skyrocketing and the pandemic surges across the country—or keep students at home until the end of the school year in June.
New Research On Flu Vaccines Sheds Light On Covid-19 Vaccines
According to a new study, vaccine-induced antibodies against influenza tend to fade relatively quickly, most within a year or less. What challenges does this foretell for Covid-19 vaccines?
The FDA Will Not Inspect Vaccine Production Plants
Approval of a vaccine by the Food and Drug Administration (FDA) typically requires inspection of the vaccine’s manufacturing plants. In a Covid-19 world, this will not be the case. Covid-19 vaccine candidates will get a pass on FDA plant inspections, a…
New Study Offers More Evidence That Immunity To Covid-19 Fades Quickly
A recently published British study found that the prevalence of Covid-19 antibodies across England has dropped more than 26 percent in three months.
Eli Lilly Stops Antibody Trial In Hospitalized Covid-19 Patients
Is this a sign that monoclonal antibodies against SARS-CoV-2 are an ineffective treatment? Not necessarily.
